| Authors: |
Fountzilas E; Department of Medical Oncology, St Luke's Clinic, Thessaloniki, Greece.; Department of Medical Oncology, European University Cyprus, German Oncology Center, Nicosia, Cyprus., Kurzrock R; WIN Consortium for Precision Medicine, Chevilly-Larue, France.; Medical College of Wisconsin, Milwaukee, WI, USA., Nishizaki D; Department of Medicine, Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego, Moores Cancer Center, La Jolla, CA, USA., Szabo A; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA., Pabla S; Labcorp, Durham, NC, USA., DePietro P; Labcorp, Durham, NC, USA., Jensen TJ; Labcorp, Durham, NC, USA., Kato S; Department of Medicine, Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego, Moores Cancer Center, La Jolla, CA, USA., Tsimberidou AM; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. |
